openPR Logo
Press release

Dr. Anil Shah Introduces Revolutionary Micro Incision Technique for Buccal Fat Removal

10-22-2024 09:48 PM CET | Fashion, Lifestyle, Trends

Press release from: ABNewswire

Dr. Anil Shah Introduces Revolutionary Micro Incision

New York, NY - 22 October, 2024 - Dr. Anil Shah, an acclaimed facial plastic surgeon based in New York City, has developed a groundbreaking technique for buccal fat removal [https://www.nosesandnecksnyc.com/]that reduces scarring and recovery time. The innovative approach, known as the Micro Incision for Buccal Fat, involves creating an incision inside the mouth smaller than the size of a tooth. This advancement represents a significant breakthrough in buccal fat removal procedures.

Traditionally, buccal fat removal has been performed using larger incisions inside the mouth, which can result in noticeable scarring and ongoing irritation for patients. Dr. Shah's technique focuses on minimizing this incision, ensuring that patients experience faster recovery and, more importantly, avoid the discomfort and long-term effects of internal scarring.

Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXeTJw8c_x6tekiqv8oWeEQH8NRjhpzoFUATRW5v_9dTzFJLozk0yQX97Cnli3bLIjNjksR-k6XdrSSpmfsLP5T3bE1TZLgiJ4gHqct7fuhafNvR4GuP8hKro-sSinTaGAivFWmh-hhkkJiuMn8RiaIixl3_?key=4JLCO_6kjVUzvbcPTHSNQA

"With a larger incision," Dr. Shah explains, "patients can constantly chew the inside of their mouth and create a permanent scar. With my micro incision technique, however, the incision mark is virtually imperceptible and essentially heals without a scar."

Another innovative element of this small incision technique is the reduced recovery time. With traditional buccal fat removal, most patients take three days to a week off to recover. With Dr. Shah's micro incision approach, however, patients are oftentimes able to return to work within a day.

This innovative method is transforming the way buccal fat removal [https://www.nosesandnecksnyc.com/] is performed, offering patients a safer and more comfortable option with outstanding cosmetic results. Dr. Shah's commitment to advancing facial plastic surgery continues to position him as a leading expert in the field.

For more information or to schedule an interview with Dr. Shah, please contact: Dr. Anil Shah - Noses and Necks NYC - 60 E 56th St #304 - New York, NY 10022 - 646.798.4905

About Dr. Anil Shah

Dr. Anil Shah [https://www.nosesandnecksnyc.com/] is a board-certified facial plastic surgeon specializing in advanced cosmetic surgery techniques. With his practice located on prestigious Park Avenue, he is at the forefront of facial surgery innovations, consistently developing safer and more effective methods for his patients.

Dr. Shah is widely recognized for his precision, artistry, and commitment to patient safety. His expertise spans a range of procedures, including rhinoplasty, facelifts, and non-surgical facial rejuvenation, attracting patients from across the globe. In addition to his innovative approach to buccal fat removal, Dr. Shah is a sought-after speaker and educator, frequently sharing his knowledge with peers and mentoring the next generation of surgeons.

Dr. Anil Shah, MD

Noses and Necks NYC

60 East 56th Street, Suite 304

New York, NY 10022

Phone: 646.798.4905

For more information please visit: https://www.nosesandnecksnyc.com/

For media inquiries please contact at Email: shahmddesign@gmail.com OR practicemanager@shahmd.com

Media Contact
Company Name: Noses and Necks NYC
Contact Person: Aurora Z
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=dr-anil-shah-introduces-revolutionary-micro-incision-technique-for-buccal-fat-removal]
Country: United States
Website: https://www.nosesandnecksnyc.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dr. Anil Shah Introduces Revolutionary Micro Incision Technique for Buccal Fat Removal here

News-ID: 3705179 • Views:

More Releases from ABNewswire

Sky-Blue Revolutionizes Inflight Service with Bespoke, Sustainable Design Solutions for Airlines Worldwide
Sky-Blue Revolutionizes Inflight Service with Bespoke, Sustainable Design Soluti …
Reading, Berkshire, UK - October 15, 2025 - Sky-Blue, a pioneering British design and sourcing company specializing in bespoke inflight service solutions, is redefining the way airlines approach onboard hospitality and sustainability. With a mission to "elevate your inflight experience to new heights," Sky-Blue delivers tailor-made products that blend style, practicality, and eco-conscious innovation. From cutleries and glassware to tableware, textiles, and disposables, Sky-Blue has positioned itself as a leading partner
Multiple System Atrophy Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Multiple System Atrophy Competitive Landscape 2025: Clinical Trial Analysis, The …
Multiple System Atrophy companies are Neuramedy Co.,Ltd, ProMIS Neurosciences, Enterin Inc., Nippon Chemiphar, CORESTEM, Inc, Brain Neurotherapy Bio, Inc., Kainos Medicines, Alterity Therapeutics, H. Lundbeck A/S, Biohaven, Ltd, Selecta Biosciences Inc, Ionis Pharmaceuticals, Inc, and others. "Multiple System Atrophy Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Multiple System Atrophy Market. As per DelveInsight's assessment, globally, Multiple System Atrophy pipeline
Depemokimab Market Insights 2034: Ultra-Long-Acting Anti-IL-5 Biologic for Severe Eosinophilic Asthma and CRSwNP with Global Sales Forecast by DelveInsight
Depemokimab Market Insights 2034: Ultra-Long-Acting Anti-IL-5 Biologic for Sever …
Depemokimab market report provides a comprehensive analysis of GSK's ultra-long-acting IL-5 monoclonal antibody, Depemokimab (GSK3511294), positioning it as a transformative therapy for severe eosinophilic asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and other Type-2 inflammatory disorders. DelveInsight's latest report, "Depemokimab Market Insights, Clinical Pipeline, and Sales Forecast 2034" , provides a comprehensive analysis of GSK's ultra-long-acting IL-5 monoclonal antibody, Depemokimab (GSK3511294), positioning it as a transformative therapy for severe eosinophilic asthma,
Cushing's Disease Pipeline 2025: Innovative Clinical Developments by 4+ Global Leaders - DelveInsight | Featuring Relacorilant, SPI 62, CRN-04894
Cushing's Disease Pipeline 2025: Innovative Clinical Developments by 4+ Global L …
DelveInsight's, "Cushing Syndrome - Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Cushing Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. As Cushing's disease continues to rise worldwide and contributes to

All 5 Releases


More Releases for Shah

Dr. Anil Shah Introduces Revolutionary Suture Suspension Technique for Crooked N …
New York, NY - Board-certified facial plastic surgeon Dr. Anil Shah is redefining how surgeons treat one of the most difficult nasal deformities: the crooked nose. With his innovative Suture Suspension Technique [https://www.shahfacialplastics.com/articles/crooked-nose-suture-suture-suspension-technique/], Dr. Shah offers a minimally invasive, highly effective solution that avoids many of the limitations associated with traditional rhinoplasty. The crooked nose, often caused by trauma or congenital asymmetries, has historically been a surgical challenge. Traditional techniques involve
Decoding Shah Equity: Why Noorullah Shah Hussaini Won't Sell His Cash-Printing A …
Image: https://www.globalnewslines.com/uploads/2025/06/9c8ad684657ef744f136e9aead513463.jpg The marble foyer of the Emirates Palace still hummed with post-conference chatter when Noorullah Shah Hussaini agreed to sit down for what he calls a "rare public debrief." Moments earlier the twenty-one-year-old founder of Shah Equity had speed-dated with a number of family offices at the Annual Family Office Summit in Abu Dhabi, where delegates from Riyadh to Singapore had quizzed him on topics ranging from the latest weight
Dipesh Shah, USFDA Inspector: Key Reports and Regulatory Actions
Dipesh Shah has had a prominent role in ensuring regulatory compliance within the pharmaceutical industry. With 191 inspections and 163 Form 483s issued, his inspection history highlights the critical importance of maintaining strict adherence to FDA standards. This article explores the key aspects of Shah's inspections, including his role in issuing warning letters, the duration of his inspections, and the global scope of his work. We'll also look at what
Shah Equity & Shah Health Partners: Transforming Healthcare in the Gulf
A groundbreaking collaboration between Shah Equity and Wafra International Investments has sent ripples through the Middle Eastern healthcare sector. This bold venture-a $50 million pension hospital project in Kuwait-combines cutting-edge clinical expertise, solidified financial backing, and a keen focus on high-impact specialties. At its core, Shah Equity's healthcare subsidiary, Shah Health Partners, will manage and acquire the hospital's gastrointestinal (GI) department, highlighting a pivotal moment in Gulf-region medicine. "Healthcare in the
Dr. Anil Shah Publishes Comprehensive Article on "The Aging Face"
New York, NY - January 16, 2025 - Renowned NYC, Manhattan, Park Avenue-based facial plastic surgeon Dr. Anil Shah, along with co-author Dr. Paige M. Kennedy, published the groundbreaking article "The Aging Face [https://pubmed.ncbi.nlm.nih.gov/30342607/]," which has become a cornerstone in understanding the biological and physical foundations of facial aging. The article, published in the National Institutes of Health, provides an in-depth look into the complex factors that contribute to facial
Ali Asghar Shah Drops New Track "Don't Stop Believin"
Pakistani singer, songwriter and producer Ali Asghar Shah released his latest song "Don`t Stop Believin". This is one of the first songs that Ali plans to release in 2021. Three years later, he introduced the idea of the project by releasing a new version of the song, showing that the art was never really completed and celebrating the process of becoming an artist. . "Don't stop believing" this song is